Skip to main content
Fig. 7 | Molecular Brain

Fig. 7

From: Spatiotemporal expression patterns of genes coding for plasmalemmal chloride transporters and channels in neurological diseases

Fig. 7

SLC12A2 and SLC12A5 mRNA levels in different CNS disorders. a The GClTC set enrichment analysis between health control and MS patient (p = 0.002). b The GClTC enrichment analysis between control and KA (Kainic acid)—induced epileptic model (p = 0.013). c SLC12A2 mRNA (W = 54, p = 0.035, Wilcoxon test), SLC12A5 mRNA (W = 43, p = 0.237, Wilcoxon test) normalized expression level in health control and MS patient. Values represent the median (IQR). d Slc12a2 mRNA (t(4)  = 0.683, p = 0.532, Student's t-test) and Slc12a5 mRNA (t(4) = 4.446, p = 0.028, Student's t-test) normalized expression level in health control and epileptic model. Values represent mean ± SD. *p < 0.05

Back to article page

Molecular Brain

ISSN: 1756-6606